Effectiveness and safety of long-acting aripiprazole 960 mg: preliminary findings from a prospective real-world observational study
{{output}}
Poor treatment adherence is a major challenge in the management of severe mental disorders, as it is associated with an increased risk of relapse, rehospitalization, symptom worsening, treatment resistance, and all-cause mortality. In 2023 a 2-month 960 mg for... ...
